Cargando…
Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis
Novel strain of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) causes mild to severe respiratory illness. The early symptoms may be fever, dry cough, sour throat, and difficulty in breathing which may lead to death in severe cases. Compared to previous outbreaks like SARS-CoV and Middle...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872828/ https://www.ncbi.nlm.nih.gov/pubmed/33564990 http://dx.doi.org/10.1007/s11010-020-04027-8 |
_version_ | 1783649262943338496 |
---|---|
author | Tarique, Mohammed Ahmad, Shaban Malik, Arshi Ahmad, Irfan Saeed, Mohd Almatroudi, Ahmad Qadah, Talal Murad, Manal Abdulaziz Mashraqi, Mutaib Alam, Qamre Al-Saleh, Yousef |
author_facet | Tarique, Mohammed Ahmad, Shaban Malik, Arshi Ahmad, Irfan Saeed, Mohd Almatroudi, Ahmad Qadah, Talal Murad, Manal Abdulaziz Mashraqi, Mutaib Alam, Qamre Al-Saleh, Yousef |
author_sort | Tarique, Mohammed |
collection | PubMed |
description | Novel strain of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) causes mild to severe respiratory illness. The early symptoms may be fever, dry cough, sour throat, and difficulty in breathing which may lead to death in severe cases. Compared to previous outbreaks like SARS-CoV and Middle East Respiratory Syndrome (MERS), SARS-CoV2 disease (COVID-19) outbreak has been much distressing due to its high rate of infection but low infection fatality rate (IFR) with 1.4% around the world. World Health Organization (WHO) has declared (COVID-19) a pandemic on March 11, 2020. In the month of January 2020, the whole genome of SARS-CoV2 was sequenced which made work easy for researchers to develop diagnostic kits and to carry out drug repurposing to effectively alleviate the pandemic situation in the world. Now, it is important to understand why this virus has high rate of infectivity or is there any factor involved at the genome level which actually facilitates this virus infection globally? In this study, we have extensively analyzed the whole genomes of different coronaviruses infecting humans and animals in different geographical locations around the world. The main aim of the study is to identify the similarity and the mutational adaptation of the coronaviruses from different host and geographical locations to the SARS-CoV2 and provide a better strategy to understand the mutational rate for specific target-based drug designing. This study is focused to every annotation in a comparative manner which includes SNPs, repeat analysis with the different categorization of the short-sequence repeats and long-sequence repeats, different UTR’s, transcriptional factors, and the predicted matured peptides with the specific length and positions on the genomes. The extensive analysis on SNPs revealed that Wuhan SARS-CoV2 and Indian SARS-CoV2 are having only eight SNPs. Collectively, phylogenetic analysis, repeat analysis, and the polymorphism revealed the genomic conserveness within the SARS-CoV2 and few other coronaviruses with very less mutational chances and the huge distance and mutations from the few other species. |
format | Online Article Text |
id | pubmed-7872828 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-78728282021-02-10 Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis Tarique, Mohammed Ahmad, Shaban Malik, Arshi Ahmad, Irfan Saeed, Mohd Almatroudi, Ahmad Qadah, Talal Murad, Manal Abdulaziz Mashraqi, Mutaib Alam, Qamre Al-Saleh, Yousef Mol Cell Biochem Article Novel strain of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) causes mild to severe respiratory illness. The early symptoms may be fever, dry cough, sour throat, and difficulty in breathing which may lead to death in severe cases. Compared to previous outbreaks like SARS-CoV and Middle East Respiratory Syndrome (MERS), SARS-CoV2 disease (COVID-19) outbreak has been much distressing due to its high rate of infection but low infection fatality rate (IFR) with 1.4% around the world. World Health Organization (WHO) has declared (COVID-19) a pandemic on March 11, 2020. In the month of January 2020, the whole genome of SARS-CoV2 was sequenced which made work easy for researchers to develop diagnostic kits and to carry out drug repurposing to effectively alleviate the pandemic situation in the world. Now, it is important to understand why this virus has high rate of infectivity or is there any factor involved at the genome level which actually facilitates this virus infection globally? In this study, we have extensively analyzed the whole genomes of different coronaviruses infecting humans and animals in different geographical locations around the world. The main aim of the study is to identify the similarity and the mutational adaptation of the coronaviruses from different host and geographical locations to the SARS-CoV2 and provide a better strategy to understand the mutational rate for specific target-based drug designing. This study is focused to every annotation in a comparative manner which includes SNPs, repeat analysis with the different categorization of the short-sequence repeats and long-sequence repeats, different UTR’s, transcriptional factors, and the predicted matured peptides with the specific length and positions on the genomes. The extensive analysis on SNPs revealed that Wuhan SARS-CoV2 and Indian SARS-CoV2 are having only eight SNPs. Collectively, phylogenetic analysis, repeat analysis, and the polymorphism revealed the genomic conserveness within the SARS-CoV2 and few other coronaviruses with very less mutational chances and the huge distance and mutations from the few other species. Springer US 2021-02-10 2021 /pmc/articles/PMC7872828/ /pubmed/33564990 http://dx.doi.org/10.1007/s11010-020-04027-8 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Tarique, Mohammed Ahmad, Shaban Malik, Arshi Ahmad, Irfan Saeed, Mohd Almatroudi, Ahmad Qadah, Talal Murad, Manal Abdulaziz Mashraqi, Mutaib Alam, Qamre Al-Saleh, Yousef Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis |
title | Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis |
title_full | Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis |
title_fullStr | Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis |
title_full_unstemmed | Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis |
title_short | Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis |
title_sort | novel severe acute respiratory syndrome coronavirus 2 (sars-cov2) and other coronaviruses: a genome-wide comparative annotation and analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872828/ https://www.ncbi.nlm.nih.gov/pubmed/33564990 http://dx.doi.org/10.1007/s11010-020-04027-8 |
work_keys_str_mv | AT tariquemohammed novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis AT ahmadshaban novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis AT malikarshi novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis AT ahmadirfan novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis AT saeedmohd novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis AT almatroudiahmad novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis AT qadahtalal novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis AT muradmanalabdulaziz novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis AT mashraqimutaib novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis AT alamqamre novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis AT alsalehyousef novelsevereacuterespiratorysyndromecoronavirus2sarscov2andothercoronavirusesagenomewidecomparativeannotationandanalysis |